期刊文献+

肝型和无症状型肝豆状核变性颅脑磁共振分析 被引量:5

MR imaging analysis of the brain in patients with hepatic form and asymptomatic type of Wilson's disease
下载PDF
导出
摘要 目的观察肝型和无症状型的肝豆状核变性颅脑MRI表现。方法对我院2014年5月-2016年5月收治的97例肝型和28例无症状型WD患者,均行头部MRI检查。结果 125例患者中颅脑磁共振检查发现有108例患者(87.8%)有脑部异常信号样改变,其中肝型83例,无症状型25例;83例有脑萎缩改变,肝型63例,无症状型20例。结论肝型和无症状型肝豆状核变性患者颅脑MRI异常信号比例较高,主要集中在壳核;信号改变主要为对称性长T_1和长T_2,未发现有混杂样信号改变;病程与脑干和壳核相关,发病年龄与壳核、苍白球、尾状核密切相关;Child-Pugh分级与颅脑磁共振改变没有明显相关性。 Objective To observe the expression of MRI in liver type and asymptomatic type of Wilson ’ s disease. Methods 97 cases of liver type and 28 patients with asymptomatic WD patients in our hospital from May 2014 to May 2016 were enrolled,all underwent brain MRI examination .Results 108 patients (87.8%) had abnormal brain signal changes with MRI scan ,including 83 cases of hepatic type ,25 cases of asymptomatic type ,83 cases of brain atrophy ,63 ca-ses of liver type ,and 20 cases without symptoms .Conclusions The proportion of MRI abnormal signals in liver type and no symptoms of hepatolenticular degeneration patients brain were higher ,mainly concentrated in the putamen;signal changes mainly for symmetric long T1 and long T2,not found a mixed sample signal change;course of disease was related with brain stem and putamen ,age of onset and putamen ,globus pallidus ,were closely related to the caudate nucleus;child Pugh classi-fication and brain magnetic resonance changes did not show any significant correlation .
出处 《中风与神经疾病杂志》 CAS 北大核心 2016年第11期1013-1016,共4页 Journal of Apoplexy and Nervous Diseases
基金 国家自然科学基金(81102592) 安徽省高校省级自然科学研究项目(KJ2013Z170)
关键词 肝豆状核变性 磁共振成像 肝型 无症状型 Wilson’ s disease Magnetic resonance imaging Hepatic form Asymptomatic type
  • 相关文献

参考文献4

二级参考文献37

  • 1梁秀龄,陈曦,李洵桦,黄丽,石铸,汤其强.肝豆状核变性临床若干问题[J].中华神经科杂志,2005,38(1):57-59. 被引量:54
  • 2李丽,李桂英,吕毅.肝豆状核变性11例诊断体会[J].脑与神经疾病杂志,1997,5(2):103-103. 被引量:2
  • 3Ala A, Walker AP, Ashkan K, et al. Wilson's disease. Lancet, 2007, 369:397-405.
  • 4Figus A, Angius A, Loudianos G, et al. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations. Am J Hum Genet, 1995, 57: 1318-1324.
  • 5Roberts EA, Schilsky ML; Division Gastroenterology and Nutrition. A practice guideline on Wilson disease. Hepatology, 2003, 37 : 1475-1492.
  • 6Wilson DC ,Phillips M J, Cox DW, et al. Severe hepatic Wilson's disease in preschool-aged children. J Pediatr, 2000, 137: 719- 722.
  • 7Ala A, Borjigin J, Rochwarger A, et al. Wilson disease in septuagenarian siblings : Raising the bar for diagnosis. Hepatology, 2005, 41:668-670.
  • 8Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int, 2003,23 : 139-142.
  • 9Sinha S ,Taly AB. Withdrawal of peniciUamine from zinc sulphatepenicillamine maintance therapy in Wilson's disease : promising, safe and cheap. J Neurol Sci, 2008,264: 129-132.
  • 10Brewer GJ, Hedera P, Khin KJ, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: Ⅲ. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol, 2003,60: 379-385.

共引文献280

同被引文献15

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部